Home Sectors Healthcare Recent Fundamentals: Acadia Healthcare Company (NASDAQ: ACHC)

Recent Fundamentals: Acadia Healthcare Company (NASDAQ: ACHC)


Acadia Healthcare Company trades as part of the health care providers industry and trades as part of the healthcare sector. The company CEO is Debra K. Osteen. Acadia Healthcare Co Inc operates mental healthcare facilities in the United States. It addresses behavioral abnormalities in psychiatric facilities, substance abuse facilities, and residential treatment centers.

Previous Intraday Trading Performance:

The ACHC stock showed a previous change of 2.42% with an open at 32.26 and a close of 33.00. It reached an intraday high of 33.23 and a low of 32.18.

Business Wire:  Acadia Healthcare to Present at Jefferies 2019 Healthcare Conference


The stock has a market cap of $2.9b with 88.4m shares outstanding, of which the float is 87.3m shares. Trading volume reached 674,233 shares compared to its average volume of 728,665 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.

Historical Trading Performance:

Over the last five trading days, Acadia Healthcare Company shares returned 1.20% and in the past 30 trading days it returned 11.34%. Over three months, it changed 9.38%. In one year it has changed -17.42% and within that year its 52-week high was 45.35 and its 52-week low was 24.27. ACHC stock is 35.97% above its 52 Week Low.

Our calculations show a 200 day moving average of 32.68 and a 50 day moving average of 31.34. Currently ACHC stock is trading 0.98% above its 200 day moving average and may be a good opportunity to buy.

SeekingAlpha:  Acadia Healthcare to explore possible sale of UK operations


The last annual fiscal EPS for the company was reported at -2.01 that ended on 31st of December 2018. Based on 8 analyst estimates, the consensus EPS for the next quarter is 0.35. The TTM EPS is 2.24, which comes to a TTM PE of 14.73.

Below was the last reported quarterly diluted earnings per share:

1stQtr of 2019 (Reported on 04/30/2019): 0.34
4thQtr of 2018 (Reported on 02/28/2019): -3.80
3rdQtr of 2018 (Reported on 11/05/2018): 0.53
2ndQtr of 2018 (Reported on 07/30/2018): 0.67
1stQtr of 2018 (Reported on 05/01/2018): 0.58

Base on our calculations, the intrinsic value per share is 41.46, which means it is possibly undervalued and has a margin of safety of 20.40%.

Indicators to Watch:

The current calculated beta is 0.63.

SeekingAlpha:  Acadia Healthcare to explore possible sale of UK operations

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is -8.10%, return on assets is -3.08%, profit margin is -6.47%, price-to-sales is 0.94 and price-to-book is 1.19.

Company Scores:

All scores are out of six:
 2  :Valuation Score
 0  :Past Performance Score
 1  :Financial Strength Score
 3  :Future Growth Score
 0  :Dividend Score
 1  :Overall Score

John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.